Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Spirapril | |
| Synonyms |
|
|
| Definitions |
A prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Spirapril is converted in the body to its active metabolite spiraprilat. Spiraprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Spiraprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C66560 |
|
| CAS_Registry |
83647-97-6
|
|
| Chemical_Formula |
C22H30N2O5S2
|
|
| code |
C66560
|
|
| Contributing_Source |
FDA
|
|
| definition |
A prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Spirapril is converted in the body to its active metabolite spiraprilat. Spiraprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Spiraprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.
|
|
| FDA_UNII_Code |
96U2K78I3V
|
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Spirapril
|
|
| Legacy Concept Name |
Spirapril
|
|
| Preferred_Name |
Spirapril
|
|
| prefixIRI |
NCIT:C66560
|
|
| prefLabel |
Spirapril
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0075007
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping